| ²é¿´: 1497 | »Ø¸´: 4 | ||
¾²Ò¹Ö®Ë¼Ìú¸Ëľ³æ (ÕýʽдÊÖ)
ÔÆÓ°
|
[ÇóÖú]
¼±£¡ÇóÖúÓйش󳦸˾ú°¢À²®ÌÇÆô¶¯×Ó±í´ïµÄ¾ÑéÒÔ¼°ÎÄÕ¡£ ÒÑÓÐ1È˲ÎÓë
|
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
p43Æô¶¯×ÓÔڴ󳦸˾úÖÐÒ²ÄÜÆô¶¯»ùÒòµÄת¼Âð
ÒѾÓÐ5È˻ظ´
¹ØÓÚ±í´ïÔØÌå ת»¯´ó³¦¸Ë¾ú ½øÐÐÀ©·±µÄÎÊÌâ
ÒѾÓÐ9È˻ظ´
ÇëÍÆ¼öÊʺϰ¢À²®ÌÇÆô¶¯×Ó±í´ïϵͳµÄ´ó³¦¸Ë¾úËÞÖ÷
ÒѾÓÐ3È˻ظ´
Çó´óÉñÖ¸µã ²»Í¬ÖÖÀàµÄ´ó³¦¸Ë¾ú¶ÔÃÜÂë×ӵį«ºÃÐÔÓÐÉùôӰÏ죿
ÒѾÓÐ8È˻ظ´
ÖÊÁ£µ¼Èë´ó³¦¸Ë¾úµ¼²»½øÈ¥£¬Çó¸ßÊÖÖ¸µã
ÒѾÓÐ16È˻ظ´
´ó³¦¸Ë¾ú×é³ÉÐͱí´ïÔØÌå
ÒѾÓÐ8È˻ظ´
Çó¿ÉÒÔ˵Ã÷Ö÷¿ÍÌå·Ö×Óʶ±ðµÄʵÑé
ÒѾÓÐ10È˻ظ´
35sÆô¶¯×ÓÆô¶¯µÄ»ùÒòÔÚ¸ù£¬¾¥£¬Ò¶Öеıí´ï£¬²î±ðºÜ´ó
ÒѾÓÐ5È˻ظ´
ÎÒÏëÖªµÀ£¬pQE30ÖеÄT5Æô¶¯×Ó
ÒѾÓÐ7È˻ظ´
ÇëÉè¼ÆÒ»ÖÖ¼ì²âË«Æç¸Ë¾ú²úÆ·ÖеĴ󳦸˾úÊýÄ¿µÄʵÑé·½°¸
ÒѾÓÐ5È˻ظ´
CMVÆô¶¯×ÓµÄÎÄÕÂ
ÒѾÓÐ9È˻ظ´
´ó³¦¸Ë¾úµÄ¼×»ùºìʵÑéºÍVPʵÑé
ÒѾÓÐ4È˻ظ´
Çó´ó³¦¸Ë¾ú lpp£¨Ö¬µ°°×£©Æô¶¯×ÓµÄÐòÁÐ~ лл~~~~~ÔÚÏßµÈ
ÒѾÓÐ3È˻ظ´
ÖÊÁ£µ¼Èë´ó³¦¸Ë¾ú
ÒѾÓÐ9È˻ظ´
¡¾ÇóÖú/½»Á÷¡¿´ó³¦¸Ë¾úÓеÄÊDZí´ïÔØÌåµÄËÞÖ÷£¬ÓÐЩÊ¿ËÂ¡ÔØÌåµÄËÞÖ÷£¬ËûÃǵÄÇø±ðÔÚÄÄ£
ÒѾÓÐ10È˻ظ´
¡¾ÇóÖú/½»Á÷¡¿ÇëÎÊÓÐËÖªµÀEFÆô¶¯×ÓÊÇʲô£¿
ÒѾÓÐ3È˻ظ´
¡¾ÇóÖú/½»Á÷¡¿ÓÕµ¼´ó³¦¸Ë¾ú²úÉú¦Â°ëÈéÌÇÜÕøҪ¼Ó¶àÉÙÈéÌÇ
ÒѾÓÐ4È˻ظ´
¡¾ÇóÖú/½»Á÷¡¿ÔØÌåµÄ²¡¶¾Æô¶¯×Ó£¨¶¯Îïϸ°ûÖбí´ïÄ¿µÄ»ùÒò£©Ì½ÌÖ
ÒѾÓÐ10È˻ظ´
¡¾ÇóÖú/½»Á÷¡¿ÔÚ¹¹½¨»ùÒò±í´ïÔØÌåµÄʱºòʲôʱºòÐèÒªÈËΪµØÔÚÉÏÃæ¼ÓÉÏÆô¶¯×Ó£¿
ÒѾÓÐ6È˻ظ´

ptttmt
Òø³æ (ÕýʽдÊÖ)
- Ó¦Öú: 85 (³õÖÐÉú)
- ½ð±Ò: 1216.4
- ºì»¨: 12
- Ìû×Ó: 519
- ÔÚÏß: 192.8Сʱ
- ³æºÅ: 3621717
- ×¢²á: 2014-12-31
- רҵ: ²¡¶¾Ñ§
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
¾²Ò¹Ö®Ë¼: ½ð±Ò+25, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, лÁË£¬ÐÁ¿àÁË£¡ 2015-02-03 10:49:44
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
¾²Ò¹Ö®Ë¼: ½ð±Ò+25, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, лÁË£¬ÐÁ¿àÁË£¡ 2015-02-03 10:49:44
|
www.ncbi.nlm.nih.gov/pubmed/9790877 Protein Expr Purif. 1998 Nov;14(2):160-6. High-level expression of eukaryotic polypeptides from bacterial chromosomes. Olson P1, Zhang Y, Olsen D, Owens A, Cohen P, Nguyen K, Ye JJ, Bass S, Mascarenhas D. Author information Abstract Attractive economics and short development timelines have often been cited as reasons for using bacteria to express eukaryotic proteins on a commercial scale. Nevertheless, routine techniques for bacterial expression of heterologous proteins are beset by a variety of technical and legal difficulties. In particular, the use of plasmids to express foreign proteins, popular promoter systems, protein fusion partners, and histidine tags and the recovery of proteins from inclusion bodies are affected by a host of issued patents. Chromosomally encoded leaderless fusions (CELF) offer a variety of technical and legal advantages over existing bacterial expression systems. In this study, we show that CELF can be used to produce a wide assortment of eukaryotic proteins at 10-liter fermentation scale. Copyright 1998 Academic Press. PMID: 9790877 [PubMed - indexed for MEDLINE [ ·¢×ÔСľ³æ¿Í»§¶Ë ] |
2Â¥2015-02-02 23:11:14
ptttmt
Òø³æ (ÕýʽдÊÖ)
- Ó¦Öú: 85 (³õÖÐÉú)
- ½ð±Ò: 1216.4
- ºì»¨: 12
- Ìû×Ó: 519
- ÔÚÏß: 192.8Сʱ
- ³æºÅ: 3621717
- ×¢²á: 2014-12-31
- רҵ: ²¡¶¾Ñ§
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï
¾²Ò¹Ö®Ë¼: ½ð±Ò+5, ¡ïÓаïÖú, ÎÒÐèÒªÕÒµ½ÄÇÆªÍâÎÄÎÄÏ×£¬Õâ²ÅÊǽá¹û£¬ÄÚÈݲ¶àÒ²¿ÉÒÔ¡£ 2015-02-03 10:41:34
¾²Ò¹Ö®Ë¼: ½ð±Ò+5, ¡ïÓаïÖú, ÎÒÐèÒªÕÒµ½ÄÇÆªÍâÎÄÎÄÏ×£¬Õâ²ÅÊǽá¹û£¬ÄÚÈݲ¶àÒ²¿ÉÒÔ¡£ 2015-02-03 10:41:34
|
ÎÄÏ×ÒѾÕÒµ½£¬ÈçÉÏ£¬½ð±Ò½±Àø¶à¸øµã£¬ÎÒÐèÒª´óÁ¿½ð±ÒÇóÎÄÏ×Óã¡Ð»Ð»£¡ ²Î¿¼£ºÆÚ¿¯¡¶ÉúÃü¿ÆÑ§¡·£¬ÎÄÕ£º¡¶ÍâÔ´»ùÒòÔڴ󳦸˾úÖеĸßЧ±í´ï¡·£¬×÷ÕߣºÁÎÃÀµÂ£¬»ªÄÏÀí¹¤´óѧ£¬ http://www.docin.com/touch_new/preview_new.do?id=618721204 Äã½ØÈ¡Í¼Æ¬µÄÎÄ×Ö²¿·Ö¼û¸ÃÎÄÏ׵ĵڶþÒ³ÓÒϽǶÎÂ䣡£¡¸ù¾Ý²Î¿¼ÎÄÏ×5²éµ½ÉÏÊöÓ¢ÎÄÎÄÏ×£¡£¡ [ ·¢×ÔСľ³æ¿Í»§¶Ë ] |
3Â¥2015-02-02 23:26:14
ptttmt
Òø³æ (ÕýʽдÊÖ)
- Ó¦Öú: 85 (³õÖÐÉú)
- ½ð±Ò: 1216.4
- ºì»¨: 12
- Ìû×Ó: 519
- ÔÚÏß: 192.8Сʱ
- ³æºÅ: 3621717
- ×¢²á: 2014-12-31
- רҵ: ²¡¶¾Ñ§
4Â¥2015-02-02 23:31:54
¾²Ò¹Ö®Ë¼
Ìú¸Ëľ³æ (ÕýʽдÊÖ)
ÔÆÓ°
- Ó¦Öú: 4 (Ó×¶ùÔ°)
- ½ð±Ò: 4460.9
- É¢½ð: 1931
- ºì»¨: 179
- Ìû×Ó: 950
- ÔÚÏß: 602.2Сʱ
- ³æºÅ: 3146442
- ×¢²á: 2014-04-18
- ÐÔ±ð: GG
- רҵ: ΢ÉúÎïÉúÀíÓëÉúÎﻯѧ

5Â¥2015-02-03 10:39:33












£©£¬Òò¶ø¼±ÓÚÇóÖú¸÷λ´óÉñ°ï棡ֻ֪µÀÊÇ1998ÄêµÄÒ»¸ö½ÐOlsonµÄ×÷ÕßдµÄ£¬ÓùȸèѧÊõËÆºõûËѵ½ÕæÕýÒªµÄ£¬Ö»ÒªÕÒ¶ÔÎÄÕ£¬ÄÄÅÂÊǰѱêÌâºÍÕªÒªÕÒ¶Ô¶¼¿ÉÒÔÁË£¬¸Ðл£¡
»Ø¸´´ËÂ¥